CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-06 | FRENKEL JACOB A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-04-06 | Abbhi Sankesh Director | Grant or award | +4,657 | 4,657 | ||
| 2020-03-09 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 151,540 | ||
| 2020-02-01 | Polverino Anthony J. Director | Grant or award | +3,071 | 15,862 | ||
| 2019-12-24 | Kern Ralph Dr. COO and Chief Medical Officer | Purchase | +3,000 | $3.88 | $12K | 115,655 |
| 2019-12-24 | Shah Preetam EVP, CFO and Treasurer | Purchase | +11,600 | $3.96 | $46K | 36,600 |
| 2019-12-24 | Araya Arturo Chief Commercial Officer | Purchase | +3,000 | $3.90 | $12K | 8,608 |
| 2019-12-12 | Yablonka Uri EVP and Chief Business Officer | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2019-12-12 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2019-12-12 | Polverino Anthony J. Director | Grant or award | +2,000 | 12,791 | ||
| 2019-12-12 | Almenoff June Sherie Director | Grant or award | +2,000 | 2,000 | ||
| 2019-12-12 | TAUB MALCOLM S Director | Grant or award | +12,000 | 53,332 | ||
| 2019-09-06 | Shah Preetam EVP, CFO and Treasurer | Grant or award | +25,000 | 25,000 | ||
| 2019-09-06 | Shah Preetam EVP, CFO and Treasurer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-09-06 | Shah Preetam EVP, CFO and Treasurer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-08-28 | ARBEL IRIT Director | Option exercise | +6,666 | $2.25 | $15K | 162,499 |
| 2019-08-28 | ARBEL IRIT Director | Option exercise | +6,666 | $2.25 | $15K | 169,165 |
| 2019-08-28 | ARBEL IRIT Director | Sale | −13,332 | $3.67 | $49K | 155,833 |
| 2019-08-28 | ARBEL IRIT Director | Option exercise · Stock Option (right to buy) | −6,666 | 0 |
Page 6 of 7 · 127 trades